Skip to content

To find the role of Punarnava syrup and Dhatri syrup in anemic children.

A DOUBLE BLIND CLINICAL TRIAL OF PUNARNAVA SYRUP AND DHATRI SYRUP IN THE MANAGEMENT OF PANDU ROG WITH SPECIAL REFERENCE ANEMIA IN CHILDREN. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102405
Enrollment
60
Registered
2026-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

State Ayurvedic College and hospital, Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either gender from age 6 to 11 years. 2.Patients having classical signs and symptoms of Pandu Roga as mentioned in Ayurvedic texts. 3.Children with hemoglobin level less than 11.5g/dl and above 8g/dl. 4.Microcytic hypochromic anemia.

Exclusion criteria

Exclusion criteria: 1.Patients having age less than 6 years and above 11years. 2.Blood Hb less than 8g/dl. 3.Any other type of anemia except IDA. 4.IDA with any associated severe complications. 5.Children with any congenital anomalies and genetic disorders.

Design outcomes

Primary

MeasureTime frame
1.Improvement in overall health condition of the patient. 2.Improvement in hemoglobin level after the trial. 3.Improvement in symptoms of anemia such as fatigue, dizziness, and shortness of breath.Timepoint: 12th week

Secondary

MeasureTime frame
1.To evaluate the efficacy of Punarnava syrup and Dhatri syrup. 2.To improve the quality of life.Timepoint: After completing 8 weeks of clinical trial.

Countries

India

Contacts

Public ContactDr Mahesh Narayan Gupta

State Ayurvedic college hospital, Lucknow

mngupta75@yahoo.com9415447523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026